Reduction of Neuroinflammation as a Common Mechanism of Action of Anorexigenic and Orexigenic Peptide Analogues in the Triple Transgenic Mouse Model of Alzheimer´s Disease

Anna Mengr(Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry), Lenka Maletı́nská(Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry)
Journal of Neuroimmune Pharmacology
February 11, 2025
10.1007/s11481-025-10174-w
Cited by 4

Related Papers

Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity
|PLoS ONE|2017|50
Age-related metabolic and neurodegenerative changes in SAMP8 mice
|Aging|2022|44
Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity- and age-induced peripheral insulin resistance: a study in Zucker rats
|BMC Neuroscience|2014|37
Lipidized PrRP Analog Exhibits Strong Anti-Obesity and Antidiabetic Properties in Old WKY Rats with Obesity and Glucose Intolerance
|Nutrients|2023|9
Cholecystokinin system is involved in the anorexigenic effect of peripherally applied palmitoylated prolactin-releasing peptide in fasted mice
|Physiological Research|2021|8